Leenaerts; Joseph Elisabeth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leenaerts; Joseph Elisabeth.The latest application filed is for "tau pet imaging ligands".

Company Profile

2.18.23

Leenaerts; Joseph Elisabeth - Rijkovorsel BE
Leenaerts; Joseph Elisabeth - Rijkevorsel BE
Leenaerts; Joseph Elisabeth - Beerse BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tau Pet Imaging Ligands App 20220024896 - Andres-Gil; Jose Ignacio ; et al.	2022-01-27
Tau PET imaging ligands Grant 11,168,068 - Andres-Gil , et al. November 9, 2	2021-11-09
Tau Pet Imaging Ligands App 20210283277 - MOECHARS; Diederik Willem Elisabeth ; et al.	2021-09-16
Oga Inhibitor Compounds App 20210277003 - Bartolome-Nebreda; Jose Manuel ; et al.	2021-09-09
Oga Inhibitor Compounds App 20210130352 - Bartolome-Nebreda; Jose Manuel ; et al.	2021-05-06
Tau Pet Imaging Ligands App 20190284165 - Andres-Gil; Jos ANDReS-GIL ; et al.	2019-09-19
Tau Pet Imaging Ligands App 20190038784 - MOECHARS; Diederik Willem Elisabeth ; et al.	2019-02-07
Morpholinothiazoles as alpha 7 positive allosteric modulators Grant 8,637,510 - Macdonald , et al. January 28, 2	2014-01-28
Quinoline or isoquinoline substituted P2X7 antagonists Grant 8,431,704 - Love , et al. April 30, 2	2013-04-30
Morpholinothiazoles As Alpha 7 Positive Allosteric Modulators App 20120238561 - Macdonald; Gregor James ; et al.	2012-09-20
Quinoline Or Isoquinoline Substituted P2x7 Antagonists App 20110092481 - Love; Christopher John ; et al.	2011-04-21
Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,795,261 - Janssens , et al. September 14, 2	2010-09-14
Use of anti-histaminics for acute reduction of elevated intracranial pressure Grant 7,732,437 - Tegtmeier , et al. June 8, 2	2010-06-08
Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,572,786 - Janssens , et al. August 11, 2	2009-08-11
Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists Grant 7,514,424 - Janssens , et al. April 7, 2	2009-04-07
Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine Grant 7,476,662 - Janssens , et al. January 13, 2	2009-01-13
Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,435,736 - Janssens , et al. October 14, 2	2008-10-14
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,410,970 - Janssens , et al. August 12, 2	2008-08-12
Substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage Grant 7,390,822 - Janssens , et al. June 24, 2	2008-06-24
Novel Substituted 4-Phenyl-4[H-Imidazol-2-YL]-Piperidine Derivatived And Their Use As Selective Non-Peptide Delta Opioid Agonists App 20080096925 - Janssens; Frans Eduard ; et al.	2008-04-24
Novel Formulations For Opioid-Based Treatments Of Pain Comprising 1-(1,2-Disubstituted Piperidinyl)-4-Substituted Piperazine Derivatives App 20080070924 - Janssens; Frans Eduard ; et al.	2008-03-20
Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists Grant 7,282,508 - Janssens , et al. October 16, 2	2007-10-16
Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists App 20070213346 - Janssens; Frans Eduard ; et al.	2007-09-13
Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives as selective non-peptide delta opiod agonists with antidepressant and anxiolytic activity App 20060287345 - Steckler; Thomas Horst Wolfgang ; et al.	2006-12-21
Antihistaminic spiro compounds Grant 7,148,214 - Janssens , et al. December 12, 2	2006-12-12
Antihistaminic spiro compounds Grant 7,087,595 - Janssens , et al. August 8, 2	2006-08-08
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists App 20060167008 - Janssens; Frans Eduard ; et al.	2006-07-27
Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives App 20060128721 - Janssens; Frans Eduard ; et al.	2006-06-15
Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists App 20060074069 - Janssens; Frans Eduard ; et al.	2006-04-06
Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists App 20060058285 - Janssens; Frans Eduard ; et al.	2006-03-16
Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists App 20060040950 - Janssens; Frans Eduard ; et al.	2006-02-23
Use of anti-histaminics for acute reduction of elevated intracranial pressure App 20050070525 - Tegtmeier, Frank ; et al.	2005-03-31
Antihistaminic spiro compounds App 20050026901 - Janssens, Frans Eduard ; et al.	2005-02-03
Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage App 20050004170 - Janssens, Frans Eduard ; et al.	2005-01-06
Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists App 20040260096 - Janssens, Frans Eduard ; et al.	2004-12-23
Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine App 20040167138 - Janssens, Frans Eduard ; et al.	2004-08-26
Fused imidazole derivatives as multidrug resistance modulators App 20030087895 - Janssens, Frans Eduard ; et al.	2003-05-08
1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives Grant 6,521,621 - Janssens , et al. February 18, 2	2003-02-18
1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives Grant 6,197,772 - Janssens , et al. March 6, 2	2001-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.